Pathogenesis of Anemia during Human Immunodeficiency Virus Infection
- 1 May 2001
- journal article
- review article
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 49 (3) , 225-239
- https://doi.org/10.2310/6650.2001.33967
Abstract
Anemia is common during human immunodeficiency virus (HIV) infection1and is associated with increased progression to AIDS2and higher mortality.3It is estimated that up to 90% of adults and children develop anemia during HIV infection, especially in late disease.4,5Fatigue is a common manifestation of anemia during HIV infection.6Several etiologic factors have been implicated in the anemia associated with HIV infection, including deficiencies of iron, folate, vitamin B12, and vitamin A,7the anemia of chronic disease,8impaired erythropoietin production,9endogenous release of inhibitory cytokines,10 Mycobacterium avium complex infection,11human parvovirus B19 infection,12HIV infection of hematopoietic progenitor cells,13HIV infection of other bone marrow stromal cells,14and antiretroviral therapy.15The cause of anemia during HIV infection is often multifactorial with several mechanisms occurring simultaneously in a single patient (Figure 1). This report reviews the epidemiology, pathogenesis, diagnosis, and treatment of anemia associated with HIV infection, with an emphasis on gaps in knowledge and current research issues. Some of the existing data on anemia and HIV infection was collected before the advent of highly active antiretroviral therapy (HAART) in the late 1990s. The incidence and prevalence of anemia may have changed now in populations receiving HAART, but many of the observations made before HAART are relevant to most HIV-infected individuals worldwide. More than 90% of individuals infected with HIV live in developing countries where antiretroviral therapy is largely unavailable.16 Figure 1. Interactions of factors involved in the pathogenesis of anemia. Abbreviations: MAC, Mycobacterium avium * complex; CMV, cytomegalovirus; TFN, tumor necrosis factor; IFN, interferon. The prevalence of anemia during HIV infection seems to vary widely by demographic characteristics of the population and stage of the disease. The prevalence of anemia is generally higher in …Keywords
This publication has 116 references indexed in Scilit:
- Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South AfricaAIDS, 1999
- Haematological characteristics and HIV status of pregnant women in Abidjan, Côte d'Ivoire, 1995–1996Transactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Atypical hemolytic uremic syndrome in human immunodeficiency virus-1-infected childrenPediatric Nephrology, 1997
- Parvovirus B19 infection in HIV-1 infected patients with anemiaInfection, 1994
- Inadequate erythropoietin response to anemia: definition and clinical relevanceAnnals of Hematology, 1994
- Inhibitory effect of HIV-1 envelope glycoproteins gp120 and gp160 on the in vitro growth of enriched (CD34+) hematopoietic progenitor cellsArchiv für die gesamte Virusforschung, 1992
- Incidence of Mycobacterium avium-intracellulare Complex Bacteremia in Human Immunodeficiency Virus-Positive PatientsThe Journal of Infectious Diseases, 1992
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Predictors of the Acquired Immunodeficiency Syndrome Developing in a Cohort of Seropositive Homosexual MenNew England Journal of Medicine, 1987